|
Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
| 6,500 GBX | +4,84% |
|
+5,69% | -34,01% |
| 05/05 | Shield Therapeutics plc, Q1 2026 Sales/ Trading Statement Call, May 05, 2026 | |
| 01/05 | RISULTATI E TRADING: ProService Building Services taglia le stime | AN |
Principali concorrenti
Aggiungi a una lista 0 selezionato | Fatturato (Y-1) | Margine netto (Y-1) | Margine EBIT (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | |
|---|---|---|---|---|---|---|---|
| 30,33 Mln | -84,47% | -71,08% | - | - | -0.92x | ||
| 14,34 Mrd | 31,41% | 34,05% | 16,13% | 12,48% | -1.09x | ||
| 9,09 Mrd | 20,13% | 25,95% | 14,03% | 6,99% | -0x | ||
| 3,95 Mrd | 31,29% | 39,94% | 17,59% | 11,33% | -0.18x | ||
| 15,56 Mrd | 19,3% | 28,72% | 16,36% | 7,75% | 1.74x | ||
| 9,89 Mrd | 13,07% | 28,69% | 7,39% | 4,5% | 0.68x | ||
| 5,14 Mrd | 25,03% | 31,43% | 31,7% | 22,02% | -1.81x | ||
| 1,94 Mrd | -145,16% | -158,13% | -28,87% | -21,31% | 2.03x | ||
| 1,86 Mrd | 6,24% | 5,38% | 5,01% | 2,76% | -7.32x | ||
| 3,06 Mrd | 1,69% | 28,34% | 14,97% | 0,67% | 0.88x | ||
| 638 Mln | -28,69% | -26,12% | -252,11% | -29,11% | 0.85x | ||
| 502 Mln | -144,39% | -104,25% | - | -78,14% | -2.48x | ||
| 150 Mln | 66,87% | 49,52% | 39,67% | 25,58% | 1.24x | ||
| 3,22 Mrd | 10,83% | 12,71% | 5,94% | 4,79% | -1.97x | ||
| 389 Mln | 52,64% | 41,45% | 18,91% | - | - | ||
| 8,83 Mrd | 5,34% | 18,49% | 6,14% | 2,42% | 4.83x | ||
| 260 Mln | -21,9% | -25,8% | -3,3% | - | - | ||
| 2,53 Mrd | 47,93% | 58,98% | 39,78% | 28,06% | -1.19x | ||
| 579 Mln | 28,22% | 29,21% | 10,08% | - | -1.4x | ||
| Media | 4,31 Mrd | -3,4% | 2,5% | -2,39% | 0,05% | -0,36x | |
| Media ponderata per Capi. | 7,36 Mrd | 7,16% | 13,31% | 4,04% | 3,56% | -0,30x |
- Mercati
- Azioni
- Azione STX
- Settore Shield Therapeutics plc
- Confronti finanziari
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
MarketScreener is also available in this country: United States.
Switch edition
Rimanere sul sito del Paese attuale
















